查詢結果分析
來源資料
相關文獻
- Hypopituitarism after Surgical Adenomectomy in Adult Patients with Acromegaly--A Review with Emphasis on Growth Hormone Deficiency
- 身材矮小的評估及治療
- Growth Hormone Therapy in Children with Growth Hormone Deficiency
- Precocious Puberty Associated with Growth Hormone Deficiency in a Patient with Craniopharyngioma: Report of One Case
- 分泌生長促素之腦下垂體腺瘤--目前診斷及治療之概念
- 肢端肥大症治療新藥--Pegvisomant
- Immunohistochemical Study on Nonfunctioning Pituitary Tumors
- Intraventricular Meningioma Occurring after the Transsphenoidal Removal of a Pituitary Adenoma Without Irradiation: A Case Report
- 利用Octreotide(Sandostatin)治療肢端肥大症的經驗談
- 孩童生長激素缺乏症之診斷
頁籤選單縮合
題 名 | Hypopituitarism after Surgical Adenomectomy in Adult Patients with Acromegaly--A Review with Emphasis on Growth Hormone Deficiency=肢端肥大症術後之腦下垂體荷爾蒙缺乏--著重論述生長激素缺乏之文獻回顧 |
---|---|
作 者 | 宋育民; | 書刊名 | 內科學誌 |
卷 期 | 29:4 2018.08[民107.08] |
頁 次 | 頁230-239 |
分類號 | 415.663 |
關鍵詞 | 肢端肥大症; 生長激素缺乏; 腦下垂體腺瘤; Acromegaly; Adult; Growth hormone deficiency; rhGH replacement; |
語 文 | 英文(English) |
中文摘要 | 因腦下垂體腺瘤過度分泌生長激素引起之肢端肥大症,絕大部分之病患需要以手術方式摘除腺瘤,但往往仍需輔以各類其他療法,才能將生長激素及類胰島素生長因子-1盡量控制在正常範圍,以緩解臨床症狀。然而,除了較被熟知的中樞型腎上腺低下症、甲狀腺低下症,及性腺低下症,有少數病患在術後產生生長激素缺乏的狀況,諸多心血管疾病之風險因子因而產生,如脂肪堆積,骨骼肌減少,代謝症候群,糖尿病,骨密度下降。統計顯示,這些疾患都增加了病患的患病率及死亡率;另外,在前瞻性的臨床實驗中,已證實生長激素製劑的補充療法,已可有意義的緩解前述病症之嚴重程度,此少見疾病之診斷及療法因此值得做一探討。 |
英文摘要 | Excessive secretion of growth hormone (GH) from a pituitary adenoma and the consequent increase in synthesis and secretion of insulin-like-growth factor-1 (IGF-1) from the liver causes acromegaly. Aggressive treatment is usually required for this disorder, especially for large tumors, with aims to remove the mass lesions as much as possible and correct hormonal abnormalities. In addition to the better known hypopituitarism affecting the pituitary-adrenal, -thyroid, and/or -gonadal axes, a rare but clinically significant outcome of treatment is a deficiency of GH. In the long run, this may result in a decrease in lean muscle mass, fat accumulation, and increases in the incidence of metabolic syndrome and diabetes, thereby increasing morbidity and mortality in this patient population. Poor quality of life is another dominant feature of a lack of GH. Although there is still controversy about the long term benefits for health maintenance and mortality after GH replacement, a close look into the potential benefits of replacement therapy in correction of the multiple abnormalities caused by GH and IGF-1 deficiencies is still warranted. This literature review was undertaken to raise clinical attention and concern about the recognition, diagnosis, and treatment of various forms of hypopituitarism after surgery on the pituitary gland, with emphasis on GH deficiency. |
本系統中英文摘要資訊取自各篇刊載內容。